研究证据表明,AKI患者新发或进展为慢性肾脏病(CKD)的风险增加2.67倍,尿毒症风险增加4.81倍,心血管事件风险增加38%,死亡风险增加1.80倍[1],5年再住院率达到32.4%,全球因AKI死亡人数超过200万/年,极大增加了医疗和财务成本,为患者家庭和社会带来了沉重的负担,已...
AKI的高危住院病患群,在HA-AKI患者中分别占43.7%、32%、30.3%。约1/4AKI发生在慢性肾脏病(chronic kidney disease,CKD)基础上,并且超过40%的AKI由药物导致,在高龄患者中这一比例可高达51%。常见的致病药物依次为中草药、NSAIDs、抗生素、对比剂,...
2, were renal transplant or chronic RRT (ESRD or > 1 RRT event) up to 365 days lookback before index hospitalization; absence of ICD-10 diagnosis code for AKI (N17. %); first RRT initiated outside of the ICU; use of prolonged intermittent RRT (PIRRT): 5A1D80Z (performance of ...
JAMA. 2016;315:801–10. Article CAS Google Scholar Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2012;2013(3):1–150. Google Scholar Tai BC, Machin D, White I...